Travere Therapeutics (TVTX) Amortizatization of Intangibles (2011 - 2023)

Travere Therapeutics has reported Amortizatization of Intangibles for 11 years, with the latest figure at $2.3 million in Q4 2023.

• For the quarter ending Q4 2023, Amortizatization of Intangibles rose 122.39% year-over-year to $2.3 million; the trailing twelve-month figure through Dec 2023 stood at $5.7 million (up 717.43% YoY), and the FY2025 full-year result was $4.4 million, down 2.18% from the prior year.
• Amortizatization of Intangibles for Q4 2023 stood at $2.3 million, up from $1.9 million in the prior quarter.
• The five-year high for Amortizatization of Intangibles was $2.3 million in Q4 2023, with the low at -$697000.0 in Q4 2021.
• Historically, Amortizatization of Intangibles has averaged $161333.3 across 5 years, with a median of -$155500.0 in 2020.
• Annual changes were most pronounced in 2019 — Amortizatization of Intangibles soared 295.1% — and 2020, when it sank 2022.22%.
• Travere Therapeutics' Amortizatization of Intangibles stood at $9000.0 in 2019, then slumped by 2022.22% to -$173000.0 in 2020, then plunged by 302.89% to -$697000.0 in 2021, then soared by 246.77% to $1.0 million in 2022, then jumped by 122.39% to $2.3 million in 2023.
• The last three Amortizatization of Intangibles figures came in at $2.3 million (Q4 2023), $1.9 million (Q3 2023), and $1.0 million (Q4 2022), per Business Quant data.